Intuity Medical, which makes an automated self-contained blood glucose monitor, withdrew its plans for an initial public offering on Friday. It originally filed in September 2021 with a proposed deal size of $75 million.
Intuity is a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes. Its first commercial product, the POGO Automatic Blood Glucose Monitoring System (POGO Automatic) is an FDA-cleared, automated, self-contained handheld monitor that enables patients to accurately measure blood glucose levels. In February 2020, the company initiated a limited commercial launch of POGO Automatic through its online POGO Store.
The Fremont, CA-based company was founded in 2002 and had planned to list on the Nasdaq under the symbol POGO. Goldman Sachs, Jefferies, Piper Sandler, and Raymond James were set to be the joint bookrunners on the deal.
